C.Q. Pharmaceutical Holding Co., Ltd.

XSEC:000950 Stock Report

Market Cap: CN¥8.9b

C.Q. Pharmaceutical Holding Past Earnings Performance

Past criteria checks 1/6

C.Q. Pharmaceutical Holding's earnings have been declining at an average annual rate of -5%, while the Healthcare industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 18% per year. C.Q. Pharmaceutical Holding's return on equity is 3.6%, and it has net margins of 0.5%.

Key information

-5.0%

Earnings growth rate

-5.0%

EPS growth rate

Healthcare Industry Growth7.0%
Revenue growth rate18.0%
Return on equity3.6%
Net Margin0.5%
Next Earnings Update24 Apr 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How C.Q. Pharmaceutical Holding makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

XSEC:000950 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2481,4284304,1795
30 Jun 2479,1833794,1667
31 Mar 2480,1235924,167-1
31 Dec 2380,1196554,0660
30 Sep 2375,6826904,1636
30 Jun 2375,8691,0653,7424
31 Mar 2371,5711,0063,5465
01 Jan 2367,8299523,4233
30 Sep 2266,8331,1043,2427
30 Jun 2265,0849693,5297
31 Mar 2263,9381,0383,4767
31 Dec 2162,5211,0053,36010
30 Sep 2161,0229543,1495
30 Jun 2158,2661,0222,9215
31 Mar 2152,0168802,6216
31 Dec 2045,2208842,3193
30 Sep 2039,0967552,0424
30 Jun 2034,7036241,8753
31 Mar 2033,5997261,7513
31 Dec 1933,8447881,6903
30 Sep 1932,5368881,707-1
30 Jun 1929,8978441,4830
31 Mar 1927,6417001,5120
31 Dec 1825,8036911,3870
30 Sep 1822,0211231,2331
30 Jun 1821,5017151,3021
31 Mar 1821,3856131,3011
31 Dec 1721,1905901,3130
30 Sep 1719,1701,7231,3520
31 Dec 1620,4879561,1940
31 Dec 1519,4193941,2680

Quality Earnings: 000950 has high quality earnings.

Growing Profit Margin: 000950's current net profit margins (0.5%) are lower than last year (0.9%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 000950's earnings have declined by 5% per year over the past 5 years.

Accelerating Growth: 000950's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 000950 had negative earnings growth (-37.8%) over the past year, making it difficult to compare to the Healthcare industry average (-5.7%).


Return on Equity

High ROE: 000950's Return on Equity (3.6%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/02 11:18
End of Day Share Price 2025/01/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

C.Q. Pharmaceutical Holding Co., Ltd. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Feifei XuChina Merchants Securities Co. Ltd.
Tielin ChenTopsperity Securities
Xinming ZhouTopsperity Securities